BRAIN PRINT

 

SCROLL

2016/10/24

  • Press Release

LPixel Raises $7 Million in Series A Funding to Globally Accelerate Detection of Diseases by its Practical Imaging Analysis Solutions

Tokyo, Japan ― October 24, 2016 ― LPixel, the leading life science imaging analysis startup from the University of Tokyo, announced today a Series A investment of $7 million led by JAFCO with participation from Mistletoe, Toray Engineering as well as a private investor.
LPixel, the leading life science imaging analysis startup from the University of Tokyo, announced today a Series A investment of $7 million led by JAFCO with participation from Mistletoe, Toray Engineering as well as a private investor. Toray Engineering shall also engage in business development. The financing will be used to enhance its research and development of proprietary AI technologies and to accelerate its global expansion in life science and medical industries.
LPixel offers practical solutions that academic and industrial knowledge are highly integrated since it has been dedicated to multiple joint studies with prominent medical institutions such as National Cancer Center Japan from former laboratory. Because of the overwhelming demand for assisting image diagnosing, LPixel is expanding its business. 
Moreover, Japan is an advanced medical imaging market. The number of CT and MRI instruments per 1 million population is the largest in the world and imaging analysis is an essential part of medical examination. This is a huge advantage to optimize accuracy of analysis with machine learning in terms of both quantity and quality. LPixel also aim to be a global leader and to create new era of diagnostic imaging.
About LPixel
LPixel is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPixel is dedicated to offering research facilities top-tier image analysis technologies and educational programs on preventing unintentional image fraud and plagiarism. The company is currently working with the National Cancer Center Japan to further the development of AI-based medical diagnosis software. For more information, please visit https://lpixel.net/en/
About Investors
JAFCO Co., Ltd.  http://www.jafco.co.jp/english/
Mistletoe, Inc.   http://mistletoe.co/en/
Toray Engineering Co.,Ltd. http://www.toray-eng.com/

PRODUCTS

EIRL
Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
IMACEL
AI for accelerating
your research
IMACEL instantly processes and analyzes of a large volume of images, creating an environment that enables researchers to focus on their research. Extensive knowledge on image analysis technologies is not a requirement to get started with IMACEL.

JOINT RESEARCH

PARTNERS

Alphabetical listing

CAREERS

A Third Career Option for Researchers

LPIXEL Inc.